GO
Loading...

Drug Retail

More

  • USPS Takes Armstrong to Court     Friday, 22 Feb 2013 | 1:41 PM ET

    CNBC's Brian Shactman reports the Department of Justice is joining Floyd Landis in a lawsuit accusing Lance Armstrong using performance-enhancing drugs while being sponsored by the U.S. Postal Service. Armstrong says he did not cost the government money. Instead, he says the Postal Service actually benefitted to the tune of more than $100 million from its association with the disgraced cyclist.

  • Global Fight Against Tuberculosis     Friday, 22 Feb 2013 | 1:22 PM ET

    Turberculosis is making a global comeback, including in the United States. Dr. William Schaffner of Vanderbilt University School of Medicine, discusses the concern surrounding the disease.

  • Higher Taxes Put the Brakes on Retail Spending Wednesday, 13 Feb 2013 | 8:33 AM ET

    Retail sales barely rose in January as tax increases and higher gasoline prices restrained spending. Separately, import and export prices rose slightly less than expected in the month.

  • Help Wanted: Washington Weed Czar     Wednesday, 30 Jan 2013 | 1:49 PM ET

    Washington State's liquor control board is seeking a marijuana consultant to help forge ahead regulation for its newly legalized substance. Steve Fox, director of government relations with the Marijuana Policy Project, offers insight.

  • Opko Health CEO on Cytochromas Acquisition     Monday, 28 Jan 2013 | 6:15 PM ET

    Opko Health chairman and CEO Dr. Phillip Frost, offers insight on his company's acquisition of Cytochromas, its partnerships with companies like Bristol-Meyers Squibb, and where the company is headed this year.

  • Watson Pharmaceuticals has merged with Actavis, and will now trade on the NYSE under ticker symbol ACT. Its president & CEO Paul Bisaro, discusses the U.S. economy and the generic drug industry.

  • Branding & Redemption     Thursday, 17 Jan 2013 | 1:30 PM ET

    The world is gearing up for Lance Armstrong's big interview tonight with Oprah Winfrey. Robbie Vorhaus, founder & CEO of Vorhaus Communications, weighs in.

  • Talking Numbers: Drug War Heats Up     Tuesday, 15 Jan 2013 | 3:30 PM ET

    The relative prospects for shares of Pfizer and Johnson & Johnson are debated by a fundamental analyst and a technical analyst. (2:58)

  • CVS Changes the Way It Stocks Tylenol     Tuesday, 15 Jan 2013 | 2:46 PM ET

    In the wake of Johnson & Johnson's manufacturing problems, CVS has changed the way it stocks Tylenol, reports CNBC's Bertha Coombs.

  • Lance Armstrong Confesses     Tuesday, 15 Jan 2013 | 1:44 PM ET

    NBC's Anne Thompson reports Lance Armstrong confessed to using performance enhancing drugs in an interview with Oprah Winfrey; and CNBC's Scott Cohn reports Armstrong has now complied with the subpoena for all of his medical records.

  • Breakthrough Watch: MS Drug Could Have Other Uses Wednesday, 9 Jan 2013 | 6:17 PM ET
    Health care

    Could a widely used MS treatment work on other diseases?

  • BioMarin's CEO On Its Product Pipeline     Tuesday, 8 Jan 2013 | 2:20 PM ET

    The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.

  • Death of Gift Cards? Tuesday, 8 Jan 2013 | 2:09 PM ET
    Barnes & Noble gift cards

    Retailers should be buzzing right now with holiday gift card redemptions. But, there's early evidence retailers aren't getting much of a boost from gift cards this year, according to NBG Market Analyst Brian Sozzi.

  • Onyx CEO on Partnership With Bayer     Tuesday, 8 Jan 2013 | 1:22 PM ET

    Onyx Pharmaceuticals CEO Dr. Anthony Coles discusses his company's thyroid cancer drug and its blood cancer drug and its partnership with Bayer.

  • NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.

  • Retail Sales Winners & Losers Thursday, 3 Jan 2013 | 12:27 PM ET
    Macy's shoppers

    The latest batch of retail sales reports shed light on who the retail winners are right now.

  • Antidepressants to Treat Grief?     Thursday, 27 Dec 2012 | 7:55 PM ET

    The American Psychiatric Association now says it's okay to use antidepressants for someone who is grieving over a recently lost loved one. Beverly Hills Psychiatrist Dr. Carole Lieberman, offers insight.

  • 'Pay For Delay' Case     Friday, 7 Dec 2012 | 7:25 PM ET

    The Supreme Court is taking on the "pay for delay" method used by big pharmaceutical companies, and pilots at American Airlines voted to ratify a new contract, reports CNBC's Brian Shactman.

  • Marijuana: Doobie Do's and Don'ts     Friday, 7 Dec 2012 | 2:50 PM ET

    CNBC's Jane Wells reports Washington's new state law that makes it legal to smoke pot, is more complicated than it sounds, and Allen St. Pierre, NORML executive director, weighs in on the financial benefits of reforming marijuana laws.

  • Some 150 workers at TriHealth, a Cincinnati-based health care company are unemployed today because they refused to get a free, company-sponsored flu shot. Michael Cannon, Cato Institute, thinks the company has a right to make this decision, while Barbara Fisher, National Vaccine Information Center, thinks this a violation of the workers' informed consent rights.